XML 54 R44.htm IDEA: XBRL DOCUMENT v3.20.2
GOODWILL AND INTANGIBLE ASSETS (Details) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2020
Mar. 31, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Dec. 31, 2019
Finite-Lived Intangible Assets [Line Items]            
Intangible Assets, Gross (Excluding Goodwill) $ 5,953,100,000     $ 5,953,100,000   $ 5,885,600,000
Goodwill 7,613,800,000     7,613,800,000   7,865,000,000.0
Amortization of intangibles and other assets 62,200,000   $ 61,700,000 184,600,000 $ 179,000,000.0  
Goodwill, Impairment Loss       422,400,000    
Amortization of intangible assets 62,200,000   $ 61,700,000 184,600,000 $ 179,000,000.0  
Finite-Lived Intangible Assets, Future Amortization Expense            
Estimated amortization expense, 2012 60,000,000.0     60,000,000.0    
Estimated amortization expense, 2013 238,500,000     238,500,000    
Estimated amortization expense, 2014 232,600,000     232,600,000    
Estimated amortization expense, 2015 229,500,000     229,500,000    
Estimated amortization expense, 2016 224,600,000     224,600,000    
Estimated amortization expense, Thereafter 2,380,200,000     2,380,200,000    
LabCorp Diagnostics [Member]            
Finite-Lived Intangible Assets [Line Items]            
Goodwill 3,781,700,000     3,781,700,000   3,721,500,000
Value of Goodwill Impairment Following a Percentage Change in the Discount Rate Used to Calculate Goodwill for Reporting Unit   $ 40,000,000.0        
Goodwill, Impairment Loss       3,700,000    
Impairment of Intangible Assets (Excluding Goodwill)       30,500,000    
impairment of floating rate note receivable 700,000          
Covance Drug Development [Member]            
Finite-Lived Intangible Assets [Line Items]            
Goodwill 3,832,100,000     3,832,100,000   $ 4,143,500,000
Goodwill, Impairment Loss       $ 418,700,000    
Trade Names [Member] | Covance Drug Development [Member]            
Finite-Lived Intangible Assets [Line Items]            
Impairment of Intangible Assets (Excluding Goodwill)   $ 2,700,000        
Customer Relationships [Member] | Covance Drug Development [Member]            
Finite-Lived Intangible Assets [Line Items]            
Impairment of Intangible Assets (Excluding Goodwill) 10,100,000          
Technology-Based Intangible Assets [Member] | Covance Drug Development [Member]            
Finite-Lived Intangible Assets [Line Items]            
Impairment of Intangible Assets (Excluding Goodwill) $ 17.7